Balanced Portfolio - Sell Take Profit - Resmed (RMD)
Date: 29/02/2024
*** GENERAL AVICE ONLY***
Resmed Inc. (RMD) is a global company digital health and cloud-connected medical devices. The Company design innovative solutions to treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Also, its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases
*** Trade Plan ***
Sell Take Profit – RMD. RMD has had a good recovery since being added to the balanced portfolio in October 23. During that time there have been a few profit take trims, the position is down to 1.5%. There are reports of the RMD founder selling part of his holdings, so time to sell the last portion of RMD and wait for the next opportunity
Total Portfolio Allocation: Reduce allocation from 1.5% down to 0%
Sell Take Profit RMD around $26.80
Disclaimer: The recommendation given is general advice only. It does not take into account your personal objectives, financial situation, or specific needs. This information should not be your sole resource when making such decisions. We strongly recommend you to seek the advice of financial, taxation, and legal professionals before finalising any investment decisions.